We are live on ! Find out more
DIG

Dauntless Investment Group Portfolio holdings

AUM $151M
1-Year Est. Return 76.14%
This Fund
S&P 500
This Quarter Est. Return
+11.35%
1 Year Est. Return
+76.14%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$126M
AUM Growth
-$34M
Cap. Flow
-$32.3M
Cap. Flow %
-25.65%
Top 10 Hldgs %
77.96%
Holding
92
New
27
Increased
20
Reduced
15
Closed
26

Top Buys

Rank Stock Value
1
FEMY icon
Femasys
FEMY
+$3.18M
2
AGRO icon
Adecoagro
AGRO
+$1.34M
3
MPC icon
Marathon Petroleum
MPC
+$1.11M
4
AEON icon
AEON Biopharma
AEON
+$941K
5
CGTX icon
Cognition Therapeutics
CGTX
+$756K

Top Sells

Rank Stock Value
1
AEM icon
Agnico Eagle Mines
AEM
+$4.34M
2
OKYO
OKYO Pharma
OKYO
+$4.23M
3
LCTX icon
Lineage Cell Therapeutics
LCTX
+$2.73M
4
TLSA icon
Tiziana Life Sciences
TLSA
+$1.75M
5
KZIA
Kazia Therapeutics
KZIA
+$1.01M

Sector Composition

Rank Sector Weight
1 Healthcare 7.9%
2 Consumer Staples 4.25%
3 Financials 2.79%
4 Real Estate 2.12%
5 Energy 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PPLT
51
abrdn Physical Platinum Shares ETF
PPLT
$1.99B
$128K 0.1%
6,870
-27,620
-80% -$426K
INVA icon
52
Innoviva
INVA
$1.57B
$111K 0.09%
+5,539
New +$108K
COUR icon
53
Coursera
COUR
$1.59B
$92.8K 0.07%
12,602
-56,983
-82% -$496K
AEM icon
54
Agnico Eagle Mines
AEM
$85.2B
$54.3K 0.04%
320
-25,800
-99% -$4.34M
ARMP icon
55
Armata Pharmaceuticals
ARMP
$171M
$38.5K 0.03%
+6,131
New +$33.6K
GXC icon
56
State Street SPDR S&P China ETF
GXC
$476M
$32.5K 0.03%
336
-1,323
-80% -$134K
ACON icon
57
Aclarion
ACON
$5.86M
$24.9K 0.02%
+5,422
New +$37.7K
BDX icon
58
Becton Dickinson
BDX
$48.8B
$11.3K 0.01%
58
-1,802
-97% -$343K
ATYR
59
CALL
aTyr Pharma
ATYR
$48.8M
$11K 0.01%
14,000
– –
DSL
60
DoubleLine Income Solutions Fund
DSL
$1.23B
$3.67K ﹤0.01%
326
– –
NAK
61
Northern Dynasty Minerals
NAK
$930M
$1.73K ﹤0.01%
880
-7,862
-90% -$15.2K
BAK icon
62
Braskem
BAK
$936M
$920 ﹤0.01%
+312
New +$854
KGC icon
63
Kinross Gold
KGC
$30.5B
$282 ﹤0.01%
+10
New +$260
VTYX
64
DELISTED
Ventyx Biosciences
VTYX
$9 ﹤0.01%
+1
New +$7
CRVO icon
65
CervoMed
CRVO
$26.7M
$8 ﹤0.01%
+1
New +$8
KZIA
66
Kazia Therapeutics
KZIA
$143M
$7 ﹤0.01%
1
-118,138
-100% -$1.01M
AAPL icon
67
PUT
Apple
AAPL
$4.56T
– –
-44,800
Closed -$11.4M
AFRM icon
68
PUT
Affirm
AFRM
$25.8B
– –
-16,400
Closed -$1.2M
AMZN icon
69
PUT
Amazon
AMZN
$2.93T
– –
-11,600
Closed -$2.55M
AON icon
70
Aon
AON
$76B
– –
-1,010
Closed -$360K
ATAI icon
71
AtaiBeckley Inc
ATAI
$2.67B
– –
-31,159
Closed -$165K
COYA icon
72
Coya Therapeutics
COYA
$107M
– –
-153,021
Closed -$872K
EQX icon
73
Equinox Gold
EQX
$8.44B
– –
-86,306
Closed -$968K
ETNB
74
DELISTED
89bio
ETNB
– –
-20,000
Closed -$294K
HIMS icon
75
PUT
Hims & Hers Health
HIMS
$6.94B
– –
-6,100
Closed -$346K
1 2
3
4

Similar funds

HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
BA
Brightwater Advisory Tampa, Florida $151M AUM 17.08% 1-Year Est. Return
SHF
Stage Harbor Financial Westwood, Massachusetts $151M AUM 15.9% 1-Year Est. Return
WBCM
Wilson & Boucher Capital Management Moraga, California $151M AUM 18.75% 1-Year Est. Return
MCCM
Morgan Creek Capital Management Chapel Hill, North Carolina $151M AUM
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return
FC
FACT Capital New York $150M AUM 53.4% 1-Year Est. Return
FA
FSA Advisors Troy, Michigan $152M AUM 16.73% 1-Year Est. Return

Dauntless Investment Group's Q4 2025 Portfolio in Review

As of Q4 2025, Dauntless Investment Group held 92 positions worth $126M, down 21% from $160M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Dauntless Investment Group withdrew a net $32.3M in Q4 2025, closing 26 positions and reducing 15 holdings. Its most notable exit was Lineage Cell Therapeutics, an estimated $2.73M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.9% of assets, down from 12% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Dauntless Investment Group opened a new position in Adecoagro worth $1.35M.

  • Dauntless Investment Group's largest Q4 2025 buy was Adecoagro: 170,778 shares worth $1.35M.
  • Dauntless Investment Group added most to Femasys in Q4 2025, an estimated $3.18M increase.
  • Dauntless Investment Group's biggest Q4 2025 reduction was Agnico Eagle Mines, cutting an estimated $4.34M.
  • Dauntless Investment Group fully exited Lineage Cell Therapeutics in Q4 2025, selling an estimated $2.73M.
  • Dauntless Investment Group's ten largest holdings make up 78% of its $126M portfolio in Q4 2025.
  • Dauntless Investment Group opened 27 new positions and closed 26 in Q4 2025.
  • Dauntless Investment Group's portfolio value fell 21% quarter-over-quarter to $126M.

Based on Dauntless Investment Group's 13F filing for Q4 2025, filed 17 Feb 2026.